Results 91 to 100 of about 530,197 (354)
Intrinsic subtypes and bladder cancer metastasis
Asian Journal of Urology, 2016 Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics.
David J. McConkey +3 more
doaj
Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer [PDF]
, 2017 YesOsteopontin (OPN) plays an important role in cancer progression, however its prognostic significance and its downstream factors are largely elusive.
El-Tanani, Mohamed +8 more
core +4 more sources
Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Clinical outcome measures for autoimmune encephalitis (AE) are not yet well defined. Cognitive outcome measures (CogOs) and patient‐reported outcomes (PROs) may capture the symptoms of AE, beyond clinician‐reported outcomes (ClinROs) (the Modified Rankin Scale [mRS] and Clinical Assessment Scale in Autoimmune Encephalitis [CASE ...
Tatchaporn Ongphichetmetha +8 more
wiley +1 more source
Correlation of FoxO3 Gene with Clinicopathological Features and Prognosis of Bladder Cancer Patients
Zhongliu Fangzhi Yanjiu, 2019 Objective To investigate FoxO3 expression in bladder cancer and its correlation with clinicopathological features and prognosis. Methods Bladder cancer and adjacent tissue specimens were collected from 111 patients with bladder cancer.
YANG Hanjie, LIU Geliang, LIU Bo
doaj +1 more source
Immunotherapy for bladder cancer
Research and Reports in Urology, 2015 It is nearly 40 years since Bacillus Calmette-Guérin (BCG) was first used as an immunotherapy to treat superficial bladder cancer. Despite its limitations, to date it has not been surpassed by any other treatment. As a better understanding of its mechanism of action and the clinical response to it have evolved, some of the questions around optimal ...
James S.A. Green +3 more
openaire +6 more sources
Advanced Functional Materials, EarlyView.Joule‐assisted nanotherapeutic urethral stent harnesses a smart, biodegradable magnesium stent to orchestrate spatiotemporal theragenerative therapy for urethral strictures. Magnetically induced Joule heating enables on‐demand drug release and bacterial ablation, while simultaneously guiding urothelial regeneration.
Yuhyun Na +15 more
wiley +1 more source
, 2017 Objective: Summarizing the evidence on the effects of pre- and postoperative exercise and psychosocial rehabilitation interventions on patient-reported outcomes (PROs) and physical fitness in bladder cancer patients undergoing radical cystectomy.
Bultijnck, Renée +8 more
core +1 more source
Histopathology, 2010 Proctor I, Stoeber K & Williams G H (2010) Histopathology 57, 1–13 Biomarkers in bladder cancerCancer biomarkers provide an opportunity to diagnose tumours earlier and with greater accuracy. They can also identify those patients most at risk of disease recurrence and predict which tumours will respond to different therapeutic approaches.
Ian Proctor +2 more
openaire +4 more sources
Metal Nanoclusters for Cancer Imaging and Treatment
Advanced Functional Materials, EarlyView.This review aims to provide a comprehensive summary and discussion of the core–shell design capabilities of metal nanoclusters (NCs) at the atomic level for cancer imaging and treatment. It offers essential insights into the design principles of metal NCs while also encouraging the exploration of other nanomaterials and their potential theranostic ...
Haiguang Zhu +5 more
wiley +1 more source
Proteomes, 2015 Developing a urine test to detect bladder tumours with high sensitivity and specificity is a key goal in bladder cancer research. We hypothesised that bladder cancer-specific glycoproteins might fulfill this role.
Sarah R. Ambrose +8 more
doaj +1 more source